Audhya Paul K., Chief Medical Officer of KalVista Pharmaceuticals ($KALV), made 10 open market sales of company shares over the past year, totaling about $415 thousand. His latest sale occurred on February 23, 2026. These transactions rank 6,865th among 11,678 insiders in our database, well below the average sale value of $8.6 million across 6.4 transactions per insider. He recorded no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 22, 2026 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 5000 | $0.00 | 45,000.0000 | 53,883,681 | 10.00% | 0.01% |
| Feb. 22, 2026 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 5000 | $0.00 | 144,337.0000 | 53,883,681 | 3.59% | 0.01% |
| Feb. 23, 2026 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 5354 | $15.57 | 138,983.0000 | 53,883,681 | 3.71% | 0.01% |
| Feb. 21, 2026 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 6250 | $0.00 | 139,337.0000 | 53,883,681 | 4.70% | 0.01% |
| Feb. 21, 2026 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 6250 | $0.00 | 75,000.0000 | 53,883,681 | 7.69% | 0.01% |
| Feb. 17, 2026 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 2419 | $0.00 | 2,419.0000 | 53,883,681 | 50.00% | 0.00% |
| Feb. 17, 2026 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 2419 | $0.00 | 134,250.0000 | 53,883,681 | 1.83% | 0.00% |
| Feb. 18, 2026 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 1163 | $15.00 | 133,087.0000 | 53,883,681 | 0.87% | 0.00% |
| Jan. 16, 2026 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | A | Restricted Stock Unit | 100000 | $0.00 | 100,000.0000 | 53,883,681 | 9999.99% | 0.19% |
| Nov. 22, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 5000 | $0.00 | 137,127.0000 | 53,883,681 | 3.78% | 0.01% |
| Nov. 21, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 6250 | $0.00 | 132,127.0000 | 53,883,681 | 4.97% | 0.01% |
| Nov. 22, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 5000 | $0.00 | 50,000.0000 | 53,883,681 | 9.09% | 0.01% |
| Nov. 21, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 6250 | $0.00 | 81,250.0000 | 53,883,681 | 7.14% | 0.01% |
| Nov. 24, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 5296 | $13.45 | 131,831.0000 | 53,883,681 | 3.86% | 0.01% |
| Nov. 17, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 6447 | $0.00 | 128,952.0000 | 53,883,681 | 5.26% | 0.01% |
| Nov. 18, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 3075 | $14.48 | 125,877.0000 | 53,883,681 | 2.38% | 0.01% |
| Nov. 17, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 2419 | $0.00 | 4,838.0000 | 53,883,681 | 33.33% | 0.00% |
| Nov. 17, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 4028 | $0.00 | 0.0000 | 53,883,681 | 100.00% | 0.01% |
| Aug. 22, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 5000 | $0.00 | 55,000.0000 | 49,652,878 | 8.33% | 0.01% |
| Aug. 22, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 5000 | $0.00 | 124,841.0000 | 49,652,878 | 4.17% | 0.01% |
| Aug. 25, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 2336 | $13.42 | 122,505.0000 | 49,652,878 | 1.87% | 0.00% |
| Aug. 21, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 6250 | $0.00 | 122,783.0000 | 49,652,878 | 5.36% | 0.01% |
| Aug. 22, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 2942 | $13.22 | 119,841.0000 | 49,652,878 | 2.40% | 0.01% |
| Aug. 21, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 6250 | $0.00 | 87,500.0000 | 49,652,878 | 6.67% | 0.01% |
| Aug. 17, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 6446 | $0.00 | 119,472.0000 | 49,652,878 | 5.70% | 0.01% |
| Aug. 17, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 2418 | $0.00 | 7,257.0000 | 49,652,878 | 24.99% | 0.00% |
| Aug. 18, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 2939 | $13.19 | 116,533.0000 | 49,652,878 | 2.46% | 0.01% |
| Aug. 17, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 4028 | $0.00 | 4,028.0000 | 49,652,878 | 50.00% | 0.01% |
| May 23, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 2146 | $11.31 | 113,026.0000 | 49,652,878 | 1.86% | 0.00% |
| May 22, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 5000 | $0.00 | 115,172.0000 | 49,652,878 | 4.54% | 0.01% |
| May 22, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 5000 | $0.00 | 60,000.0000 | 49,652,878 | 7.69% | 0.01% |
| May 21, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 6250 | $0.00 | 112,861.0000 | 49,652,878 | 5.86% | 0.01% |
| May 22, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 2689 | $11.88 | 110,172.0000 | 49,652,878 | 2.38% | 0.01% |
| May 21, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 6250 | $0.00 | 93,750.0000 | 49,652,878 | 6.25% | 0.01% |
| May 17, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 4028 | $0.00 | 8,056.0000 | 49,652,878 | 33.33% | 0.01% |
| May 17, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 6447 | $0.00 | 109,387.0000 | 49,652,878 | 6.26% | 0.01% |
| May 19, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 2776 | $11.84 | 106,611.0000 | 49,652,878 | 2.54% | 0.01% |
| May 17, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 2419 | $0.00 | 9,675.0000 | 49,652,878 | 20.00% | 0.00% |
| Feb. 21, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | A | Restricted Stock Units | 100000 | $0.00 | 100,000.0000 | 46,590,154 | 9999.99% | 0.21% |
| Feb. 22, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 5000 | $0.00 | 105,334.0000 | 46,590,154 | 4.98% | 0.01% |
| Feb. 24, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 2394 | $10.02 | 102,940.0000 | 46,590,154 | 2.27% | 0.01% |
| Feb. 22, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 5000 | $0.00 | 65,000.0000 | 46,590,154 | 7.14% | 0.01% |
| Feb. 17, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 4028 | $0.00 | 12,084.0000 | 46,590,154 | 25.00% | 0.01% |
| Feb. 17, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 2419 | $0.00 | 12,094.0000 | 46,590,154 | 16.67% | 0.01% |
| Feb. 18, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 3125 | $9.82 | 100,334.0000 | 46,590,154 | 3.02% | 0.01% |
| Feb. 17, 2025 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 6447 | $0.00 | 103,459.0000 | 46,590,154 | 6.65% | 0.01% |
| Nov. 26, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 2187 | $9.87 | 97,012.0000 | 46,590,154 | 2.20% | 0.00% |
| Nov. 22, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 5000 | $0.00 | 70,000.0000 | 46,590,154 | 6.67% | 0.01% |
| Nov. 22, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 5000 | $0.00 | 99,199.0000 | 46,590,154 | 5.31% | 0.01% |
| Nov. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 2419 | $0.00 | 14,513.0000 | 46,590,154 | 14.29% | 0.01% |
| Nov. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 4028 | $0.00 | 16,112.0000 | 46,590,154 | 20.00% | 0.01% |
| Nov. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Performance Stock Units | 12084 | $0.00 | 0.0000 | 46,590,154 | 100.00% | 0.03% |
| Nov. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 18531 | $0.00 | 102,276.0000 | 46,590,154 | 22.13% | 0.04% |
| Nov. 18, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 8077 | $9.26 | 94,199.0000 | 46,590,154 | 7.90% | 0.02% |
| Aug. 23, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 2135 | $12.40 | 83,745.0000 | 36,786,575 | 2.49% | 0.01% |
| Aug. 22, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 5000 | $0.00 | 85,880.0000 | 36,786,575 | 6.18% | 0.01% |
| Aug. 22, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 5000 | $0.00 | 75,000.0000 | 36,786,575 | 6.25% | 0.01% |
| Aug. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 4027 | $0.00 | 20,140.0000 | 36,786,575 | 16.66% | 0.01% |
| Aug. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 18528 | $0.00 | 88,853.0000 | 36,786,575 | 26.35% | 0.05% |
| Aug. 19, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 7973 | $12.01 | 80,880.0000 | 36,786,575 | 8.97% | 0.02% |
| Aug. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 2418 | $0.00 | 16,932.0000 | 36,786,575 | 12.50% | 0.01% |
| Aug. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Performance Stock Units | 12083 | $0.00 | 12,084.0000 | 36,786,575 | 50.00% | 0.03% |
| May 22, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | A | Restricted Stock Units | 80000 | $0.00 | 80,000.0000 | 36,786,575 | 9999.99% | 0.22% |
| May 20, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 13175 | $11.76 | 70,325.0000 | 36,786,575 | 15.78% | 0.04% |
| May 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 30614 | $0.00 | 83,500.0000 | 36,786,575 | 57.89% | 0.08% |
| May 20, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 2419 | $0.00 | 19,350.0000 | 36,786,575 | 11.11% | 0.01% |
| May 20, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Performance Stock Units | 12083 | $0.00 | 24,167.0000 | 36,786,575 | 33.33% | 0.03% |
| May 20, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Performance Stock Units | 12084 | $0.00 | 0.0000 | 36,786,575 | 100.00% | 0.03% |
| May 20, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 4028 | $0.00 | 24,167.0000 | 36,786,575 | 14.29% | 0.01% |
| Feb. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Common Stock | 30613 | $0.00 | 67,181.0000 | 0 | 83.72% | 0.00% |
| Feb. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Performance Stock Units | 12083 | $0.00 | 36,250.0000 | 0 | 25.00% | 0.00% |
| Feb. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Performance Stock Units | 12083 | $0.00 | 12,084.0000 | 0 | 50.00% | 0.00% |
| Feb. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 4028 | $0.00 | 28,195.0000 | 0 | 12.50% | 0.00% |
| Feb. 20, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | S | Common Stock | 14295 | $14.12 | 52,886.0000 | 0 | 21.28% | 0.00% |
| Feb. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | M | Restricted Stock Unit | 2419 | $0.00 | 21,769.0000 | 0 | 10.00% | 0.00% |
| Feb. 11, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | CHIEF MEDICAL OFFICER | A | Performance Stock Units | 48333 | $0.00 | 48,333.0000 | 0 | 9999.99% | 0.00% |
| Nov. 20, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | Chief Medical Officer | S | Common Stock | 7985 | $8.23 | 36,568.0000 | 0 | 17.92% | 0.00% |
| Nov. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | Chief Medical Officer | M | Restricted Stock Unit | 4028 | $0.00 | 32,223.0000 | 0 | 11.11% | 0.00% |
| Nov. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | Chief Medical Officer | M | Performance Stock Unit | 12083 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | Chief Medical Officer | M | Common Stock | 18530 | $0.00 | 44,553.0000 | 0 | 71.21% | 0.00% |
| Nov. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | Chief Medical Officer | M | Restricted Stock Unit | 2419 | $0.00 | 24,188.0000 | 0 | 9.09% | 0.00% |
| Aug. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | Chief Medical Officer | M | Restricted Stock Unit | 2418 | $0.00 | 26,607.0000 | 0 | 8.33% | 0.00% |
| Aug. 18, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | Chief Medical Officer | S | Common Stock | 8020 | $10.73 | 26,023.0000 | 0 | 23.56% | 0.00% |
| Aug. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | Chief Medical Officer | M | Common Stock | 18529 | $0.00 | 34,043.0000 | 0 | 119.43% | 0.00% |
| Aug. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | Chief Medical Officer | M | Performance Stock Unit | 12083 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | Chief Medical Officer | M | Restricted Stock Unit | 4028 | $0.00 | 36,251.0000 | 0 | 10.00% | 0.00% |
| Feb. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | Chief Medical Officer | M | Restricted Stock Unit | 4027 | $0.00 | 44,307.0000 | 0 | 8.33% | 0.00% |
| Jan. 11, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | Chief Medical Officer | A | Restricted Stock Unit | 48334 | $0.00 | 48,334.0000 | 0 | 9999.99% | 0.00% |
| May 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | Chief Medical Officer | M | Common Stock | 6447 | $0.00 | 15,794.0000 | 0 | 68.97% | 0.00% |
| May 18, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | Chief Medical Officer | S | Common Stock | 2780 | $10.14 | 13,014.0000 | 0 | 17.60% | 0.00% |
| May 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | Chief Medical Officer | M | Restricted Stock Unit | 4028 | $0.00 | 40,279.0000 | 0 | 9.09% | 0.00% |
| May 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | Chief Medical Officer | M | Restricted Stock Unit | 2419 | $0.00 | 29,025.0000 | 0 | 7.69% | 0.00% |
| Feb. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | Chief Medical Officer | M | Common Stock | 6446 | $0.00 | 6,313.0000 | 0 | 0.00% | 0.00% |
| Feb. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | Chief Medical Officer | S | Common Stock | 3412 | $7.66 | 9,347.0000 | 0 | 26.74% | 0.00% |
| Feb. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | Chief Medical Officer | M | Performance Restricted Stock Unit | 4027 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Audhya Paul K. | Chief Medical Officer | M | Restricted Stock Unit | 2419 | $0.00 | 31,444.0000 | 0 | 7.14% | 0.00% |